Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Thorax

• Publication date

  1998-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.53.10.835PMID 10193369PMCID PMC1745086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro.

  2015cited by this paper
• Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

  1996cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society.

  1995cited by this paper
• Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.

  1994cited by this paper
• Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis.

  1993cited by this paper
• The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects.

  1993cited by this paper
• Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthma.

  1993cited by this paper
• Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma.

  1993cited by this paper
• The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma

  1993cited by this paper
• In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues.

  1992cited by this paper
• Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.

  1991cited by this paper
• Endogenously formed leukotriene C4 activates LTC4 receptors in guinea pig tracheal strips.

  1991cited by this paper
• Peptide leukotriene involvement in pulmonary eosinophil migration upon antigen challenge in the actively sensitized guinea pig.

  1991cited by this paper
• Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma.

  1990cited by this paper
• Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases.

  1989cited by this paper
• Inhibition of antigen-induced contraction of guinea pig trachea by ICI 198,615.

  1989cited by this paper
• Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis.

  1989cited by this paper
• Comparative Contractile Responses to Sulfidopeptide Leukotrienes in Normal and Asthmatic Human Subjects

  1988cited by this paper
• Release of leukotrienes in patients with bronchial asthma.

  1988cited by this paper
• Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin.

  1988cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.

  1987cited by this paper
• Plasma levels of leukotrienes C4 and D4 during wheezing attack in asthmatic patients.

  1987cited by this paper
• Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig

  1985cited by this paper
• Production and antagonism of cutaneous vascular permeability in the guinea pig in response to histamine, leukotrienes and A23187.

  1984cited by this paper
• Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application.

  1981cited by this paper
• Leukotrienes are potent constrictors of human bronchi

  1980cited by this paper
• Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro.

  1980cited by this paper

• Formulation and pharmacokinetic evaluation of a single tablet formula containing montelukast sodium and fexofenadine hydrochloride

  2024cites this paper
• Cysteinyl Leukotrienes in Allergic Inflammation.

  2024cites this paper
• Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis

  2022cites this paper
• G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action

  2020cites this paper
• Does Rhinitis Pharmacotherapy Improve Control of Comorbid Asthma?

  2020cites this paper
• Exhaled Breath Analysis in Disease Detection.

  2020cites this paper
• Leukotriene D4 role in allergic asthma pathogenesis from cellular and therapeutic perspectives.

  2020cites this paper
• Current state and future prospect of the therapeutic strategy targeting cysteinyl leukotriene metabolism in asthma.

  2019cites this paper
• Impact of the genetic variants of GLCCI1 on clinical features of asthmatic patients

  2018cites this paper
• Role of genetic variations of chitinase 3-like 1 in bronchial asthmatic patients

  2018cites this paper
• Leukotriene D4 induces chemotaxis in human eosinophilc cell line, EoL-1 cells via CysLT1 receptor activation

  2017cites this paper
• Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma

  2017cites this paper
• Patient stratification and the unmet need in asthma.

  2017influential citation
• Recurrent Chronic Cough, Wheeze and their Control without Corticosteroids in 1 to 5 Year-old Children

  2016cites this paper
• Therapeutic implication of genetic variants of IL13 and STAT4 in airway remodelling with bronchial asthma

  2016cites this paper
• Physicochemical and crystal structure analysis of pranlukast pseudo-polymorphs I: anhydrates and hydrate.

  2015cites this paper
• Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis.

  2015cites this paper
• Physicochemical and crystal structure analysis of pranlukast pseudo-polymorphs II: Solvate and cocrystal.

  2015cites this paper
• Assessment of various second‐line medications in addition to inhaled corticosteroid in asthma patients: a randomized controlled trial

  2014influential citation
• Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity.

  2013cites this paper
• Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.

  2013cites this paper
• Second-Line Controller Therapy for Persistent Asthma Uncontrolled on Inhaled Corticosteroids

  2012cites this paper
• Different Modulators of Airways and Distal Lung Parenchyma Contractile Responses in the Physiopathology of Asthma

  2012cites this paper
• Pranlukast

  2012cites this paper
• Effects of Inhaled Corticosteroids, Leukotriene Receptor Antagonists, or Both, Plus Long-Acting β2-Agonists on Asthma Pathophysiology: a Review of the Evidence

  2012cites this paper
• What are the Alternatives to Increasing Inhaled Corticosteroids for the Long Term Control of Asthma?

  2012cites this paper
• Once-Daily Inhaled Corticosteroids in Children with Asthma

  2012cites this paper
• Serine Protease Inhibitor Attenuates Ovalbumin Induced Inflammation in Mouse Model of Allergic Airway Disease

  2012cites this paper
• Effect of genetic variation of IL-13 on airway remodeling in bronchial asthma.

  2011cites this paper
• Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma.

  2011cites this paper
• Medical Management of Asthma

  2010cites this paper
• Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.

  2010cites this paper
• Effects of KP-496, a novel dual antagonist for cysteinyl leukotriene receptor 1 and thromboxane A2 receptor, on Sephadex-induced airway inflammation in rats.

  2009cites this paper
• Antileukotriene Therapy in Asthma

  2009cites this paper
• Modulation de l'activation des protéases chez les éosinophiles

  2009cites this paper
• Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.

  2009cites this paper
• Airway Remodeling in Asthma and Therapeutic Implications

  2009cites this paper
• Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.

  2008cites this paper
• The Efficacy of Montelukast and Airway Mast Cell Profiles in Patients with Cough Variant Asthma

  2008cites this paper
• Airway Inflammation and Bronchial Hyperresponsiveness in Elite Cross-Country Skiers and in Patients with Newly Diagnosed Asthma : A Bronchial Biopsy Study

  2008cites this paper
• The effects of montelukast on tissue inflammatory and bone marrow responses in murine experimental allergic rhinitis: interaction with interleukin‐5 deficiency

  2007cites this paper
• Kimura Disease: Diagnostic Imaging Findings and Surgical Treatment

  2007cites this paper
• Therapeutic approach to vascular remodelling in asthma.

  2007cites this paper
• The inhibitory effect of the leukotriene receptor antagonist on leukotriene D4-induced MUC2/5AC gene expression and mucin secretion in human airway epithelial cells.

  2007cites this paper
• Cysteinyl‐leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends

  2007cites this paper
• Antileukotriene drugs: clinical application, effectiveness and safety.

  2007cites this paper
• The role of leukotrienes in airway inflammation.

  2006cites this paper
• Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.

  2006cites this paper
• Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.

  2006cites this paper
• Oral montelukast treatment of preschool-aged children with acute asthma.

  2006cites this paper
• Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.

  2006cites this paper
• The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model

  2006cites this paper
• Differential Effects of Salbutamol and Montelukast on Eosinophil Adhesion and Superoxide Anion Generation

  2006cites this paper
• Molecular mechanisms in allergy and clinical immunology

  2005cites this paper
• Effect of the Cysteinyl Leukotriene Antagonist Pranlukast on Transendothelial Migration of Eosinophils

  2005cites this paper
• Improved Case of Bronchial Asthma by Re-administration of Pranlukast from Montelukast : Evaluation of Eosinophilic Inflammation in the Peripheral Airway

  2005cites this paper
• Inflammatory basis of exercise-induced bronchoconstriction.

  2005cites this paper
• Hemopoietic progenitors: the role of eosinophil/basophil progenitors in allergic airway inflammation

  2005cites this paper
• Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa.

  2005cites this paper
• Comparison Study between the Mechanisms of Allergic Asthma Amelioration by a Cysteinyl-Leukotriene Type 1 Receptor Antagonist Montelukast and Methylprednisolone

  2005cites this paper
• Current treatment options for asthma in adults.

  2005cites this paper
• Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling

  2004cites this paper
• Platelet-Activating Factor Receptor Develops Airway Hyperresponsiveness Independently of Airway Inflammation in a Murine Asthma Model1

  2004cites this paper
• An update of the leukotriene modulators for the treatment of asthma

  2004cites this paper
• Model of Airway Inflammation in a Murine Asthma Airway Hyperresponsiveness Independently Platelet-Activating Factor Receptor Develops Takizawa

  2004cites this paper
• Leukotriene modifiers in asthma management.

  2004cites this paper
• Platelet-Activating Factor Receptor Develops Airway Hyperresponsiveness Independently of Airway Inflammation in a Murine Asthma Model

  2004cites this paper
• Effect of montelukast compared with inhaled fluticasone on airway inflammation

  2004cites this paper
• Leukotriene receptor antagonists – risks and benefits for use in paediatric asthma

  2004cites this paper
• Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.

  2004cites this paper
• Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea‐pigs

  2004cites this paper
• Current and Emerging Nonsteroidal Anti-Inflammatory Therapies Targeting Specific Mechanisms in Asthma and Allergy

  2004cites this paper
• Leukotriene D4 and eosinophil transendothelial migration, superoxide generation, and degranulation via beta2 integrin.

  2004cites this paper
• Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.

  2004cites this paper
• Anti‐inflammatory treatment for recurrent wheezing in the first five years of life

  2003cites this paper
• The role of leukotrienes in asthma.

  2003cites this paper
• Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse.

  2003cites this paper
• Up-Regulation of Cysteinyl Leukotriene 1 Receptor by IL-13 Enables Human Lung Fibroblasts to Respond to Leukotriene C4 and Produce Eotaxin

  2003cites this paper
• Pharmacotherapy and airway remodelling in asthma?

  2003cites this paper
• Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.

  2003cites this paper
• Benefit-Risk Assessment of Antileukotrienes in the Management of Asthma

  2003cites this paper
• The Roles of Cysteinyl Leukotrienes in Eosinophilic Inflammation of Asthmatic Airways

  2003cites this paper
• Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.

  2003cites this paper
• Pharmacology of airway inflammation in asthma and COPD.

  2003cites this paper
• Anti‐inflammatory effects of high‐dose montelukast in an animal model of acute asthma

  2003cites this paper
• Adenosine monophosphate bronchial provocation and the actions of asthma therapy

  2003cites this paper
• Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation.

  2003cites this paper
• Population pharmacokinetics of pranlukast hydrate dry syrup in children with bronchial asthma

  2003cites this paper
• Recent Advances in the Management of Asthma Using Leukotriene Modifiers

  2003cites this paper
• Measuring Subepithelial Thickness Using Endobronchial Ultrasonography in a Patient with Asthma: A Case Report

  2003cites this paper
• Protective effect of leukotriene receptor antagonist montelukast on smoking-induced lung injury in Wistar rats.

  2003cites this paper
• The effect of montelukast on bronchial provocation tests and exhaled nitric oxide levels in asthmatic patients.

  2003cites this paper
• Leukotriene D4 upregulates eosinophil adhesion via the cysteinyl leukotriene 1 receptor.

  2002cites this paper
• Inhaled Corticosteroids in the Management of Adult Asthma

  2002cites this paper
• Leukotriene modifiers.

  2002cites this paper
• Leukotriene modifiers

  2002cites this paper
• Leukotriene Receptor Antagonists

  2002cites this paper
• A Preliminary Study of the Impact of Managed Care on Psychotherapy in Massachusetts

  2002cites this paper
• A Functional Study on CysLT1 Receptors in Human Eosinophils

  2002cites this paper
• How to Use Anti-Allergy Drugs

  2002cites this paper